Pure Biologics SA

PQB

Company Profile

  • Business description

    Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.

  • Contact

    ul. Dunska 11
    Wroclaw54-427
    POL

    T: +48 570002829

    http://www.purebiologics.pl

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    6

Stocks News & Analysis

stocks

Investors overlooking ASX share’s potential

International expansion is a distraction from valuable local business.
stocks

Cerebras sees blockbuster demand, setting stage for US AI IPO frenzy

The chipmaker’s IPO priced at $185, well above its initial range, and opened trading at an eye-popping $350.
stocks

What did Morningstar subscribers buy and sell in April?

How the most traded shares in April stack up against our analysts views.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,870.6046.70-0.52%
CAC 407,952.55129.72-1.61%
DAX 4023,950.57505.69-2.07%
Dow JONES (US)49,526.17537.29-1.07%
FTSE 10010,195.37177.56-1.71%
HKSE25,962.73426.31-1.62%
NASDAQ26,225.14410.08-1.54%
Nikkei 22561,409.291,244.76-1.99%
NZX 50 Index12,965.0160.06-0.46%
S&P 5007,408.5092.74-1.24%
S&P/ASX 2008,630.8042.70-0.49%
SSE Composite Index4,135.3942.53-1.02%

Market Movers